BEGIN ARTICLE PREVIEW: Artificial Intelligence Collaboration Seeking to Hasten COVID-19 Insights We store cookies on your computer to improve your experience and provide more personalized services, both on this website and on other sites. For more information about the cookies we use, see our Privacy Policy. We won’t track your information when you visit our site. We will have to use at least one cookie to ensure that you won’t have to make this choice again.AcceptDeclinePrivacy Policy END ARTICLE PREVIEW READ MORE FROM SOURCE ARTICLE

IMAGE: Purdue University is joining with other organizations for an initiative to accelerate global collaborative research on COVID-19 through access to high-quality, real-time multi-center patient datasets. WEST LAFAYETTE, Ind. - During the COVID-19 pandemic, health care professionals and researchers have been confined mostly to using local and national datasets to study the impact of comorbidities, pre-existing medication use, demographics and various interventions on disease course. Now, Purdue University is joining with other organizations for an initiative to accelerate global collaborative research on COVID-19 through access to high-quality, real-time multi-center patient datasets. The National Science Foundation has provided funding to develop the Records Evaluation for COVID-19 Emergency Research (RECovER) initiative. Researchers are testing predictions of artificial intelligence drug discovery platforms from the lab of Gaurav Chopra, an assistant professor of analytical and physical chemistry in Purdue's College of Science, on patient datasets across a network of health care institutions.

IMAGE: Purdue College is becoming a member of with different organizations for an initiative to speed up world collaborative analysis on COVID-19 by means of entry to high-quality, real-time multi-center affected person datasets. WEST LAFAYETTE, Ind. – In the course of the COVID-19 pandemic, well being care professionals and researchers have been confined largely to utilizing native and nationwide datasets to review the influence of comorbidities, pre-existing remedy use, demographics and varied interventions on illness course. Now, Purdue College is becoming a member of with different organizations for an initiative to speed up world collaborative analysis on COVID-19 by means of entry to high-quality, real-time multi-center affected person datasets. The Nationwide Science Basis has supplied funding to develop the Information Analysis for COVID-19 Emergency Analysis (RECovER) initiative. Researchers are testing predictions of artificial intelligence drug discovery platforms from the lab of Gaurav Chopra, an assistant professor of analytical and bodily chemistry in Purdue's Faculty of Science, on affected person datasets throughout a community of well being care establishments.